|
1
|
Burmeister T and Reinhardt R: A multiplex
PCR for improved detection of typical and atypical BCR-ABL fusion
transcripts. Leuk Res. 32:579–585. 2008. View Article : Google Scholar
|
|
2
|
Jinawath N, Norris-Kirby A, Smith BD,
Gocke CD, Batista DA, Griffin CA and Murphy KM: A rare e14a3 (b3a3)
BCR-ABL fusion transcript in chronic myeloid leukemia: Diagnostic
challenges in clinical laboratory practice. J Mol Diagn.
11:359–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Achkar WA, Wafa A, Ali BY, Manvelyan M and
Liehr T: A rare chronic myeloid leukemia case with Philadelphia
chromosome, BCR-ABL e13a3 transcript and complex translocation
involving four different chromosomes. Oncol Lett. 1:797–800.
2010.PubMed/NCBI
|
|
4
|
Pienkowska-Grela B, Woroniecka R, Solarska
I, Kos K, Pastwińska A, Konopka L and Majewski M: Complete
cytogenetic and molecular response after imatinib treatment for
chronic myeloid leukemia in a patient with atypical karyotype and
BCR-ABL b2a3 transcript. Cancer Genet Cytogenet. 174:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fujisawa S, Nakamura S, Naito K, Kobayashi
M and Ohnishi K: A variant transcript, e1a3, of the minor BCR-ABL
fusion gene in acute lymphoblastic leukemia: Case report and review
of the literature. Int J Hematol. 87:184–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masuko M, Furukawa T, Abe T, Wada R,
Maruyama S, Kitajima T, Shibasaki Y, Toba K, Okada M and Aizawa Y:
A chronic myeloid leukemia patient with atypical karyotype and
BCR-ABL e13a3 transcript caused by complex chromosome
rearrangement. Int J Hematol. 90:230–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Braekeleer E, Douet-Guilbert N, Rowe D,
Bown N, Morel F, Berthou C, Férec C and De Braekeleer M: ABL1
fusion genes in hematological malignancies: A review. Eur J
Haematol. 86:361–371. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ito T, Tanaka H, Tanaka K, Ito K, Kyo T,
Dohy H, Kamada N and Kimura A: Insertion of a genomic fragment of
chromosome 19 between BCR intron 19 and ABL intron 1a in a chronic
myeloid leukaemia patient with micro-BCR-ABL (e19a2) transcript. Br
J Haematol. 126:752–753. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goh HG, Hwang JY, Kim SH, Lee YH, Kim YL
and Kim DW: Comprehensive analysis of BCR-ABL transcript types in
Korean CML patients using a newly developed multiplex RT-PCR.
Transl Res. 148:249–256. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Todoric-Zivanovic B, Strnad M, Stamatovic
D, Tukic L, Krtolica K, Tatomirovic Z, Djordjevic V, Bogdanovic A,
Jankovic G and Magic Z: Frequency of BCR-ABL fusion transcripts in
Serbian patients with chronic myeloid leukemia. J BUON. 16:104–107.
2011.PubMed/NCBI
|
|
11
|
Snyder DS, McMahon R, Cohen SR and Slovak
ML: Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: Benign
course responsive to imatinib with an RT-PCR Advisory. Am J
Hematol. 75:92–95. 2004. View Article : Google Scholar : PubMed/NCBI
|
